Authors
-
Caroline de Lorenzi
Division of Dermatology and Venereology, Geneva University Hospitals, rue Gabrielle-Perret-Gentil 4, CH-1205 Genève, Switzerland
Author
-
Yassaman Alipour Tehrany
Division of Dermatology and Venereology, Geneva University Hospitals, rue Gabrielle-Perret-Gentil 4, CH-1205 Genève, Switzerland
Author
-
Sébastien Menzinger
Division of Clinical Pathology, Geneva University Hospitals, rue Gabrielle-Perret-Gentil 4, CH-1205 Genève, Switzerland
Author
Keywords:
Graft-Versus, Disease, Host
Abstract
Stage IV acute cutaneous graft-versus-host-disease (GVHD) is nowadays rarely seen due to tissue typing done before transplant. The first line treatment for acute GVHD grade II-IV is systemic corticosteroids. However, although there is no consensus for refractory cases, literature report diverse therapies to be effective. We report the case of a 34 year-old patient with refractory acute cutaneous graft-versus-host-disease stage IV successfully treated with etanercept.
Author Biographies
-
Caroline de Lorenzi, Division of Dermatology and Venereology, Geneva University Hospitals, rue Gabrielle-Perret-Gentil 4, CH-1205 Genève, Switzerland
Caroline de Lorenzi. Division of Dermatology and Venereology, Geneva University Hospitals, rue Gabrielle-Perret-Gentil 4, CH-1205 Genève, Switzerland,
-
Yassaman Alipour Tehrany , Division of Dermatology and Venereology, Geneva University Hospitals, rue Gabrielle-Perret-Gentil 4, CH-1205 Genève, Switzerland
Division of Dermatology and Venereology, Geneva University Hospitals, rue Gabrielle-Perret-Gentil 4, CH-1205 Genève, Switzerland
-
Sébastien Menzinger , Division of Clinical Pathology, Geneva University Hospitals, rue Gabrielle-Perret-Gentil 4, CH-1205 Genève, Switzerland
Division of Clinical Pathology, Geneva University Hospitals, rue Gabrielle-Perret-Gentil 4, CH-1205 Genève, Switzerland
